In Depth 15 Feb 2024 Biogen: how is the biotech giant pivoting from a failed Alzheimer’s drug? …and the safety concerns alive even though there wasn’t sufficient evidence to link those events to the drug. Adding to its troubles, Biogen withdrew its application for marketing authorization of… February 15, 2024 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Opinion 17 Nov 2025 Precision psychiatry is the future of mental healthcare …serves on Barnard’s Leadership Council at Athena Center. She is a presenter at national biotech industry events, has been featured in numerous publications, and frequently speaks on issues pertaining to… November 17, 2025 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 1 Feb 2023 How can cancer care be improved? Labiotech recently asked several biotech experts the same question about tackling cancer, for a special newsletter to commemorate World Cancer Day on February 4. The 2023 theme is Close the… February 1, 2023 - 7 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 26 Sep 2017 British Biotech Pockets Massive Series C for its CAR-T Cancer Therapies …the infrastructure to rapidly bring a CAR-T cell therapy to the market. Autolus prevents cancer cells from escaping the immune system by reprogramming T cell receptors (TCRs) using powerful chimeric… September 26, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 27 Jun 2024 The 2024 drug approval list: Eight new treatments you should know about …American biotech Madrigal Pharmaceuticals’ accelerated approval came after the drug had a successful phase 3 trial where there was reduction in non-alcoholic fatty liver disease (NAFLD) activity score – a… June 27, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 16 Dec 2019 Amarin’s Triglyceride-Lowering Drug Gets Second FDA Nod to Tackle Cardiovascular Disease …it less affordable for biotech companies. There is also the risk of the trial failing, as happened with the Belgian company Celyad and the French biotech Cerenis in recent years…. December 16, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 12 Jul 2022 First patient receives new immunotherapy drug for HIV in clinical trial …plc, a UK-based, commercial-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases including cancer,… July 12, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 26 Feb 2025 New non-opioid pain medication: How is the biotech industry fighting pain after the opioid crisis? …the end of the decade. Joseph Stauffer, chief medical officer (CMO) of Antibe Therapeutics, told Labiotech that the opioid crisis has “profoundly” impacted how biotech and pharmaceutical companies now approach… February 26, 2025 - 13 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 16 Nov 2022 Poolbeg-led consortium awarded €2.3m to develop oral vaccine platform …In comparison to intramuscular injections, which generate systemic immunity, this approach prevents infections from taking hold in the body by counteracting them at the point of entry. This has the… November 16, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 7 Aug 2018 Update: Seaweed-Derived Treatment for Common Cold Approved in the EU Update (07/08/2018): Marinomed Biotech has obtained EU approval to sell a nasal spray containing a polymer derived from red seaweed that can trap most common cold viruses to stop them… August 7, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 17 Jun 2020 €30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug A Series A round closed by Barcelona-based startup Ona Therapeutics will finance the preclinical development of a drug that prevents cancer from spreading in the body by targeting the metabolism… June 17, 2020 - 2 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 10 Oct 2016 Meet the French CEO who wants to Break Barriers to Drug Delivery The objective of the French biotechnology company, Vect-Horus, is to leverage its technology, VECTrans, to facilitate the delivery of drugs into the brain and other organs. For this innovation, the… October 10, 2016 - 5 minutesmins - By Marie Godar Share WhatsApp Twitter Linkedin Email